
    
      REBECCA study will consist in a monocentric prospective cohort that will include 120 women
      volunteers treated with adjuvant tomotherapy for breast cancer in the Institut Regaud
      Claudius-Toulouse (ICR) and followed for 2 years after radiotherapy.

      In summary, women aged between 40 and 70 years, surgically treated at ICR for breast cancer
      and for whom adjuvant radiotherapy with tomotherapy is indicated, with no indication of
      chemotherapy will be eligible for the study.
    
  